|
...Percutaneous million plus up to an additional $30 million in payments upon the achievement of key milestones. Consistent with earlier disclosures, the company expects to take an initial in-process research and development charge related to this transaction in...
NOTE: All illustrations and photos
have been removed from this article.
More articles from BIOTECH Patent News
Protein Design Labs receives license fees for humanized antibodies.(Pr..., February 01, 2004
Alnylam licenses gene silencing technology from Cold Spring Harbor.(Al..., February 01, 2004
Neurogen, Merck agreement for pain drugs cleared.(Neurogen Corporation..., February 01, 2004
Enzon and INEX form partnership for oncology therapy.(Enzon Pharmaceut..., February 01, 2004
Alnylam grants RNAx license to key patent in RNA interference.(German ..., February 01, 2004
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
%20%20&position=1)